4/A//SEC Filing
BURZIK CATHERINE M 4/A
Accession 0001209191-23-008138
CIK 0000884624other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:07 PM ET
Size
5.2 KB
Accession
0001209191-23-008138
Insider Transaction Report
Form 4/AAmended
BURZIK CATHERINE M
Director
Transactions
- Award
Common Stock
2023-01-05+14,354→ 33,056 total
Footnotes (3)
- [F1]Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.
- [F2]This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.
- [F3]Includes 29,174 deferred stock units.
Documents
Issuer
Orthofix Medical Inc.
CIK 0000884624
Entity typeother
Related Parties
1- filerCIK 0001261141
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 6:07 PM ET
- Size
- 5.2 KB